We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong’s PCR Lab Solution Safeguards 2022 G20 Indonesia Summit

By LabMedica International staff writers
Posted on 03 Jan 2023
Print article
Image: Tianlong`s PCR lab solution provided protection at the G20 summit in 2022 in Indonesia (Photo courtesy of Tianlong)
Image: Tianlong`s PCR lab solution provided protection at the G20 summit in 2022 in Indonesia (Photo courtesy of Tianlong)

Tianlong Science and Technology (Shaanxi, China) safeguarded a successful G20 summit in 2022 in Indonesia, which has been one of the company’s largest overseas markets. Before the G20 summit, Tianlong's PCR lab solution was applied in several healthcare centers locally, including the Jakarta international airport. The company’s solution helps conduct nucleic acid testing for inbound and outbound passengers, and protected the gateway to Indonesia during the COVID-19 phase.

Tianlong’s star products – the Gentier 96 Real-Time PCR system and Libex nucleic acid extractor – have received high praise from clients in Indonesia due to their high efficiency and stable quality. The Gentier 96E/96R real-time fluorescence quantitative PCR detection system is tailored to meet the needs of high-end users. The product has many advantages, such as a scientific and efficient temperature control system and photoelectric system, powerful and easy-to-use software analysis function, humanized control mode, etc., and can easily realize the application of downstream multiple gene detection, quantitative analysis, SNP analysis, fusion curve analysis and so on. It is widely used in medical institutions, universities and research institutes, CDC, exit inspection and Quarantine Bureau, public security criminal investigation and material evidence identification center, veterinary station, food enterprises and dairy products factories.

Tianlong’s Libex nucleic acid extractor, which is based on the automated extraction method of magnetic bead adsorption separation, overcomes the shortcomings of conventional nucleic acid extraction methods and achieve rapid and efficient sample preparation. With the appropriate nucleic acid extraction reagents, it can process serum, plasma, whole blood, swabs, amniotic fluid, feces, tissue and tissue lavage, paraffin sections, bacteria, fungi and other sample types. The Libex nucleic acid extractor is widely used in the fields of disease prevention and control, animal quarantine, clinical diagnosis, entry-exit inspection and quarantine, food and drug administration, forensic medicine, teaching and scientific researches.

Tianlong continues to innovate to make better products and offer better services to its customers worldwide. The company continues to cooperate with its clients and jointly develop better solutions for the global markets.

Related Links:
Tianlong Science and Technology

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.